Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells

Neoplasia

Volumn 8, Issue 3, 2006, Pages 173-180

  Lo, Angela Kwok Fung ^a,b   Kwok, Wai Lo ^a   Sai, Wah Tsao ^c   Hing, Lok Wong ^c   Hui, Jan Wai Ying ^a   Ka, Fai To ^a   Hayward, S Diane ^b   Yiu, Loon Chui ^a   Yu, Lung Lau ^c   Takada, Kenzo ^d   Huang, Dolly P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cell signaling; Epstein Barr virus; Nasopharyngeal carcinoma; NF B; STAT3

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NEOMYCIN; STAT3 PROTEIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LATENT PERIOD; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS INFECTION;

EID: 33646338489     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.05625     Document Type: Article

References (29)

1. Lo KW, To KF, and Huang DP (2004). Focus on nasopharyngeal carcinoma. Cancer Cell 5, 423-428.
2. Young LS and Rickinson AB (2004). Epstein-Barr virus: 40 years on. Nat Rev Cancer 4, 757-768.
3. Young LS and Murray PG (2003). Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22, 5108-5121.
4. Portis T and Longnecker R (2004). Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 23, 8619-8628.
5. Scholle F, Bendt KM, and Raab-Traub N (2000). Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol 74, 10681-10689.
6. Nanbo A, Inoue K, Adachi-Takasawa K, and Takada K (2002). Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J 21, 954-965.
7. Imai S, Nishikawa J, and Takada K (1998). Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72, 4371-4378.
8. Lin CT, Chan WY, Chen W, Huang HM, Wu HC, Hsu MM, Chuang SM, and Wang CC (1993). Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 68, 716-727.
9. Huang DP, Ho JH, Poon YF, Chew EC, Saw D, Lui M, Li CL, Mak LS, Lai SH, and Lau WH (1980). Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer 26, 127-132.
10. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, and Lee JC (1999). Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 83, 121-126.
11. Tsao SW, Wang X, Liu Y, Cheung YC, Feng H, Zheng Z, Wong N, Yuen PW, Lo AK, Wong YC, et al. (2002). Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 1590, 150-158.
12. Lo AK, Liu Y, Wang XH, Huang DP, Yuen PW, Wong YC, and Tsao GS (2003). Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1. Lab Invest 83, 697-709.
13. Maruo S, Yang L, and Takada K (2001). Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. J Gen Virol 82, 2373-2383.
14. Chan AS, To KF, Lo KW, Mak KF, Pak W, Chiu B, Tse GM, Ding M, Li X, and Lee JC Jr (2000). High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 60, 5365-5370.
15. Lo AK, Huang DP, Lo KW, Chui YL, Li HM, Pang JC, and Tsao SW (2004). Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells. Int J Cancer 109, 919-925.
16. Chang Y, Tung CH, Huang YT, Lu J, Chen JY, and Tsai CH (1999). Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J Virol 73, 8857-8866.
17. Hirano T, Ishihara K, and Hibi M (2000). Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19, 2548-2556.
18. Chen H, Hutt-Fletcher L, Cao L, and Hayward SD (2003). A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J Virol 77, 4139-4148.
19. Bowman T, Garcia R, Turkson J, and Jove R (2000). STATs in oncogenesis. Oncogene 19, 2474-2488.
20. Hsiao JR, Jin YT, Tsai ST, Shiau AL, Wu CL, and Su WC (2003). Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis. Br J Cancer 89, 344-349.
21. Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M, and Pagano JS (2001). Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci USA 98, 6905-6910.
22. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, et al. (2002). Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21, 2000-2008.
23. Chan KS, Sano S, Kiguchi K, Anders J, Komazawa N, Takeda J, and DiGiovanni J (2004). Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 114, 720-728.
24. Guang-Wu H, Sunagawa M, Jie-En L, Shimada S, Gang Z, Tokeshi Y, and Kosugi T (2000). The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. Laryngoscope 110, 2066-2069.
25. Welte T, Zhang SS, Wang T, Zhang Z, Hesslein DG, Yin Z, Kano A, Iwamoto Y, Li E, Craft JE, et al. (2003). STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci USA 100, 1879-1884.
26. Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola D, et al. (2004). Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 10, 48-54.
27. Paukku K and Silvennoinen O (2004). STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. Cytokine Growth Factor Rev 15, 435-455.
28. Brender C, Lovato P, Sommer VH, Woetmann A, Mathiesen AM, Geisler C, Wasik M, and Odum N (2005). Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. Leukemia 19, 209-213.
29. Wong HL, Wang X, Chang RC, Jin DY, Feng H, Wang Q, Lo KW, Huang DP, Yuen PW, Takada K, et al. (2005). Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress. Mol Carcinog 44, 92-101.